Pectikon 30 mL Suspension
PDF Leaflet Revision Date: 28 October 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of mild to moderate acute non-infective diarrhoea.
Dosage (summary)
Adults: 15 mL to 30 mL three to four times daily.
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- May reduce absorption of other medicines.
- Avoid concomitant use with alcohol.
Contraindications
- Hypersensitivity to active substances or excipients.
- Intestinal obstruction.
- Spastic bowel conditions.
Common side effects
- Constipation.
- Flatulence.
- Distension.
- Intestinal obstruction.
Counselling Points
- Maintain hydration during treatment.
- Consult a doctor if symptoms persist beyond 48 hours.
Serious warnings
- Avoid use in patients with intestinal obstruction.
- May cause allergic reactions in susceptible individuals.
Important Disclaimer
The Pectikon 30 mL Suspension professional information leaflet below is the property of Gulf Drug Company and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
